The TRIUMPH-1 trial's fascinating outcomes for Retatrutide hint at enhanced weight loss potential, especially compared to tirzepatide's SURMOUNT-1 trial reports
Crucially, this study shifted the scientific paradigm from a simple model of "glutathione depletion" to a model of an "overwhelmed compensatory mechanism." The discovery that circulating immune cells in these patients actually have elevated glutathione levelswhile simultaneously suffering from a severe depletion of other protective enzymes like SOD2revealed that the cells are desperately, and unsuccessfully, trying to fight off a catastrophic level of oxidative damage
This is thought to be related to a transient vasodilation effect
Originally used to treat type 2 diabetes, GLP-1 drugs have recently become popular to assist in weight loss, either through off-label use or, in specific cases, as an One such GLP-1 medication is In addition to use for the treatment of type 2 diabetes and obesity, previous research has also looked at using liraglutide to treat other conditions including polycystic ovary syndrome (PCOS), Now researchers from Imperial College London, in the United Kingdom, recently presented research at the Alzheimers Association International Conference 2024 reporting that liraglutide may also help protect the brain from developing Alzheimers disease by reducing Their study has not yet appeared in a peer-reviewed journal
8 , e2865 (2014)
It works through a mix of actions, shielding neurons from damage, reducing oxidative stress, and helping brain cells grow and adapt
.jpg)
